Nurse administered telephone intervention for blood pressure control: A patient-tailored multifactorial intervention

Patient Education and Counseling

Volumn 57, Issue 1, 2005, Pages 5-14

  Bosworth, Hayden B ^a,b   Olsen, Maren K ^a,c   Gentry, Pam ^a   Orr, Melinda ^a   Dudley, Tara ^a   McCant, Felicia ^a   Oddone, Eugene Z ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Adherence; Education; Hypertension; Nurse; Self management; Tailored intervention

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIZZINESS; EXERCISE TOLERANCE; FACE EDEMA; FEMALE; FLUSHING; FOLLOW UP; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE AVAILABILITY; HEART PALPITATION; HUMAN; HYPERTENSION; IMPOTENCE; LEG EDEMA; LETHARGY; MAJOR CLINICAL STUDY; MALE; NURSE ADMINISTRATOR; NURSING; PATIENT COMPLIANCE; PATIENT INFORMATION; POLYURIA; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL SUPPORT; SOLDIER; SOMNOLENCE; TACHYCARDIA; TELEPHONE; TONGUE; WHEEZING; XEROSTOMIA;

EID: 15944394816     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2004.03.011     Document Type: Article

References (61)

1. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 289:2003;2560-2571
2. Weiler P.G., Camel G.H., Chiappini M., et al. Systolic hypertension of the elderly program (SHEP). Part 9. Behavioral characteristics. Hypertension. 17:1991;II152-II161
3. Gueyffier F., Froment A., Gouton M. New meta-analysis of treatment trials in hypertension: Improving the estimate of therapeutic benefit. J Hum Hypertens. 10:1996;1-8
4. Patsy B., Smith N.L., Siscovick D.S., et al. Health outcomes associated with anti-hypertensive therapies used as first line agents: A systematic review and meta-analysis. JAMA. 277:1997;739-745
5. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 335:1990;827-838
6. Veterans Administration Cooperative Study Group on antihypertensive agents. Effects of treatment of morbidity in hypertension: results in patients with diastolic blood pressure averaging 115-129 mmHg. JAMA 1967;302:1028-34.
7. Veterans Administration Cooperative Study Group on antihypertensive agents: II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-52.
8. Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 335:1990;827-838
9. Lever A., Ramsay L.E. Treatment of hypertension in the elderly. J Hypertens. 13:1995;571-579
10. US Renal, Data System. URSDS 1997 annual report. Bethesda, MD: US Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Disease; 1997.
11. Levy D., Larson M.G., Vasan R.S., et al. The progression from hypertension to congestive heart failure. JAMA. 275:1996;1557-1562
12. National Heart, Lung, and Blood Institute. Fact Book Fiscal Year 1996. Bethesda, MD: US, Department of Health and Human Services, National Institutes of Health; 1997.
13. DeBusk R.F., West J.A., Miller N.H., Taylor C.B. Chronic disease management: treating the patient with disease(s) vs treating disease(s) in the patient. Arch Intern Med. 159:1999;2739-2742
14. DeBusk R.F., Houston Miller N., West J.A. Diabetes case management. Ann Intern Med. 130:1999;863
15. Smith P.M., Kraemer H.C., Miller N.H., DeBusk R.F., Taylor C.B. In-hospital smoking cessation programs: who responds, who doesn't? J Consult Clin Psychol. 67:1999;19-27
16. DeBusk R.F., Miller N.H., Superko H.R., et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 120:1994;721-729
17. Szilagyi P., Bordley C., Vann J.C., et al. Effect of patient reminder/recall interventions rates. JAMA. 284:2000;1820-1827
18. Wasson J., Gaudette C., Whaley F., et al. Telephone care as a substitute for routine clinic follow-up. JAMA. 267:1992;1788-1793
19. Weinberger M., Tierney W.M., Cowpar P.A., et al. Cost-effectiveness of increased telephone contact for patients with osteoarthritis: a randomized controlled trial. Arthritis Rheum. 26:1993;243-246
20. Eraker S., Kirscht J.P., Becker M.H. Understanding and improving patient compliance. Ann Intern Med. 100:1984;258-268
21. Bosworth H.B., Oddone E.Z. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc. 94(4):2002;236-248
22. Bosworth HB, Olsen MK, Oddone, EZ. The role of patient and provider feedback and blood pressure control. Am Heart J [in press].
23. Curry S., Wagner E.H., Gorthaus L.C. Evaluation of intrinsic and extrinsic motivation interventions with a self help smoking cessation program. J Consult Clin Psychol. 59:1991;318-324
24. Stretcher V., Kreuter M.W., DenBoer D.J., et al. The effects of tailored smoking cessation messages in family practice setting. J Fam Practice. 39:1994;262-270
25. Rimer B., Orleans C.T., Fleisher L., et al. Does tailoring matter? The impact of a tailored guide on ratings of short-term smoking-related outcomes for older smokers. Health Educ Res. 9:1994;69-84
26. Kreuter M.W., Bull F.C., Clark E.M., Oswald D.L. Understanding how people process health information: a comparison of tailored and nontailored weight-loss materials. Health Psychol. 18(5):1999;487-494
27. Woolf B. Customer specific marketing. New York: Rand McNally; 1992.
28. McNeil B.J., Pauker S.G., Sox H.C. Jr., Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med. 306:1982;1259-1262
29. O'Connor A.M., Pennie R.A., Dales R.E. Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol. 49:1996;1271-1276
30. Tversky A., Kahneman D. The framing of decisions and the psychology of choice. Science. 211(4481):1981;453-458
31. Kahneman D., Tversky A. Prospect theory: an analysis of decisions under risk. Econometrica. 47:1979;262-291
32. Treiber F.A. A comparison of the positive and negative consequences approaches upon car restraint usage. J Pediatr Psychol. 11(1):1986;15-24
33. Detweiler J.B., Bedell B.T., Salovey P., Pronin E., Rothman A.J. Message framing and sunscreen use: gain-framed messages motivate beach-goers. Health Psychol. 18(2):1999;189-196
34. Leonetti G., Lonati L., Cuspidi C. Hypertension and diabetes in women. J Hypertens. 20(Suppl 2):2002;S23-S25
35. Zanchetti A., Hansson L., Dahlof B., et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens. 19:2001;1149-1159
36. Hunt S.C., Williams R.R., Barlow G.K. A comparison of positive family history definitions for defining risk of future disease. J Chron Dis. 39:1986;809-821
37. Misselbrook D., Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract. 51:2001;276-279
38. Hux J.E., Naylor C.D. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment? Med Decision Making. 15:1995;152-157
39. Malenka D.J., Baron J.A., Johansen S., Wahrenberger J.W., Ross J.M. The framing effect of relative and absolute risk. J Gen Intern Med. 8(10):1993;543-548
40. Parker R.M., Baker D.W., Williams M.V., Nurss J.R. The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills. J Gen Intern Med. 10:1995;537-541
41. Kaplan S.H., Gandek B., Greenfield S., et al. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 33:1995;1176-1187
42. Svetkey L.P., Moore T.J., Simons-Morton D.G., et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens. 19:2001;1949-1956
43. Moore T.J., Conlin P.R., Ard J., Svetkey L.P. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertens. 38:2001;155-158
44. Sacks F.M., Svetkey L.P., Vollmer W.M. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 344:2001;3-10
45. Jette A., Cummings K.M., Brock B.M. The structure and reliability of health belief indices. HSR. 16:1981;81-98
46. Bosworth HB. Hoff J, Box T, et al. Patient factors related to poor blood pressure control. Poster presented at the 19th Annual Health Service Research and Development Meetings. Washington, DC; 2001.
47. Morisky E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 24:1986;67-74
48. George C.F., Peveler R.C., Heiliger S., Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 50:2000;166-171
49. Stephenson B.J., Rowe B.H., Haynes R.B., et al. Is this patient taking the treatment as prescribed? JAMA. 269:1993;2779-2781
50. McGovern P., Burke G.L., Sprafka J.M. Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990: The Minnesota Heart Survey. JAMA. 268:1992;753-759
51. Brown R.J., Whisnant J.P., Sicks J.D., et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989s. Stroke. 27:1996;373-380
52. US Department of Health and Human Services. Healthy People 2010. Washington DC: US Department of Health and Human Services; 2000.
53. Desharnais R., Bouillon J., Godin G. Self-efficacy and outcome expectations as determinants of exercise adherence. Psychol Rep. 59:1986;155-159
54. McAuley E., Jerome G.J., Marquez D.X., et al. Exercise self-efficacy in older adults: social, affective, and behavioral influences. Ann Behav Med. 25:2003;1-7
55. Gwaltney C.J., Schiffman S., Paty J.A., et al. Using self-efficacy judgments to predict characteristics of lapses to smoking. J Consulting Clin Psychol. 70:2002;1140-1149
56. Molassiotis A., Nahas-Lopez V., Chung W.Y., et al. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS. 13:2002;301-310
57. Safren S.A., Otto M.W., Worth J.L., et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 39:2001;1151-1162
58. Perry H., Roccella E.J. Conference report on stroke mortality in the southeastern United States. Hypertension. 31:1998;1206-1215
59. Haynes R., Taylor D.W., Sackett D.L. Can simple clinical measurement detect patient noncompliance? Hypertension. 2:1980;759-782
60. Ley P. Communicating with patients. London: Croom Helm; 1988.
61. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 1997.